![]() | ![]() |
Formats:
|
||||||||||||||||||||||||
Copyright Kulkarni et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. E1 Ubiquitin-Activating Enzyme UBA-1 Plays Multiple Roles throughout C. elegans Development 1Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, United States of America 2Center for Advanced Research in Biotechnology, University of Maryland Biotechnology Institute, Rockville, Maryland, United States of America Mary Mullins, Editor University of Pennsylvania School of Medicine, United States of America * E-mail: smithh/at/umbi.umd.edu Conceived and designed the experiments: MK HES. Performed the experiments: MK HES. Analyzed the data: MK HES. Wrote the paper: MK HES. Received February 13, 2008; Accepted June 18, 2008. This article has been cited by other articles in PMC.Abstract Poly-ubiquitination of target proteins typically marks them for destruction via the proteasome and provides an essential mechanism for the dynamic control of protein levels. The E1 ubiquitin-activating enzyme lies at the apex of the ubiquitination cascade, and its activity is necessary for all subsequent steps in the reaction. We have isolated a temperature-sensitive mutation in the Caenorhabditis elegans uba-1 gene, which encodes the sole E1 enzyme in this organism. Manipulation of UBA-1 activity at different developmental stages reveals a variety of functions for ubiquitination, including novel roles in sperm fertility, control of body size, and sex-specific development. Levels of ubiquitin conjugates are substantially reduced in the mutant, consistent with reduced E1 activity. The uba-1 mutation causes delays in meiotic progression in the early embryo, a process that is known to be regulated by ubiquitin-mediated proteolysis. The uba-1 mutation also demonstrates synthetic lethal interactions with alleles of the anaphase-promoting complex, an E3 ubiquitin ligase. The uba-1 mutation provides a sensitized genetic background for identifying new in vivo functions for downstream components of the ubiquitin enzyme cascade, and it is one of the first conditional mutations reported for the essential E1 enzyme in a metazoan animal model. Author Summary Proteins that control an organism's development must first be turned on at the proper time and place, and then turned off when they are no longer needed. One of the “off” signals occurs through the attachment of a small protein, known as ubiquitin, to the target protein, which typically leads to the destruction of the target. Attachment of ubiquitin is controlled by a series of enzymes, the first of which is known as E1. Most organisms have a single gene for the E1 enzyme, and its activity is crucial for the degradation of a wide range of target proteins throughout development. We have identified a temperature-sensitive mutation in the E1 enzyme of the nematode Caenorhabditis elegans. By manipulating the growth temperature, we have determined the various functions of E1 at different stages of development. We find that this enzyme controls embryonic and larval development, sperm fertility, and body size. We also characterized sex-specific roles for E1; males exhibit progressive paralysis and defects in the tail, which is used for mating. In addition to the knowledge gained, this mutation provides a means of identifying both the functions of other ubiquitin enzymes during development as well as the target proteins that are marked for destruction. Introduction Post-translational modification of proteins performs a critical role in regulating protein activity, and ubiquitin-mediated proteolysis has emerged as the key player in the control of protein turnover. Ubiquitin, a highly conserved small protein, is covalently attached to a target protein through an enzymatic cascade, and the assembly of a poly-ubiquitin chain typically specifies that protein for rapid degradation via the 26S proteasome [1]. Ubiquitin-mediated proteolysis thus provides an “off” switch for governing the spatial and temporal distribution of proteins that are no longer needed. This mode of regulation is essential for normal cellular processes (e.g., cell cycle progression and differentiation), and defects have been implicated in human diseases such as cancers and neurodegenerative disorders [2],[3]. Ubiquitination of target proteins can also regulate function by mechanisms other than proteasome-mediated degradation. Mono-ubiquitination serves a signal for endocytosis and trafficking of various cell surface proteins, and is also implicated in histone and transcription factor regulation [4]–[6]. The assembly of poly-ubiquitin chains can occur at different lysines within ubiquitin, which promotes different outcomes for the labeled protein. Conjugation at lysine 48 typically leads to proteasomal degradation, while linkage through lysine 63 can modulate protein activities in processes as diverse as nuclear localization, DNA repair, or inclusion formation in neurodegenerative diseases [7]–[9]. A trio of enzymes mediates the attachment of ubiquitin to substrate protein: the E1 ubiquitin-activating enzyme, E2 ubiquitin-conjugating enzyme, and E3 ubiquitin ligase [10]. Repeated cycles of ligation to the initial ubiquitin lead to poly-ubiquitination. Substrate specificity is conferred by the selective binding of individual E3 ligases to one or a few target proteins [11]. Eukaryotes typically possess a single gene encoding the E1-activating enzyme, tens of E2-conjugating enzymes, and as many as several hundred E3 ligases. Some E3 ligases are themselves multi-subunit complexes, in which a substrate recognition subunit specifies the protein targeted for ubiquitination. In vivo roles for ubiquitination in organismal development have been determined primarily through the characterization of specific E3 ligases. In the nematode Caenorhabditis elegans, E3 ligases regulate processes as diverse as sex determination, cell cycle progression, and synaptic signaling [12]–[16]. Studies of E2 conjugating enzymes indicate interactions with multiple E3s, as their relative numbers would predict. For example, inactivation of ubc-2 produces a broader range of phenotypes than inactivation of its known E3 partner apc-11 [17]. One of the best-characterized functions for ubiquitination and proteasomal degradation in C. elegans is the coordination of early events of embryogenesis [18]. The anaphase-promoting complex (APC) is a multi-subunit E3 ligase that is essential for completion of meiosis immediately after fertilization of the oocyte by the sperm [19],[20]. Ubiquitin-mediated proteolysis also plays a role in the degradation of several proteins that are involved in establishment of anterior-posterior (A-P) polarity in the early embryo. These proteins become asymmetrically localized at the first cell division, and failure to degrade these components correlates with developmental defects such as changes in cell fate specification and embryonic lethality. Formation of the A-P axis and progression of the embryonic cell cycle requires the activities of a class of E3 complexes known as Cullin-RING ligases [21]–[27]. Mutations in components of the APC also affect A-P polarity, possibly as a consequence of defects in meiosis [28],[29]. The E1 ubiquitin-activating enzyme lies at the apex of the enzymatic cascade, and manipulation of its activity might provide a crucial entry point for identifying the myriad roles performed by ubiquitin during development. Temperature-sensitive alleles of E1 have been identified in mammalian cell lines as cell cycle mutations that exhibit reduced ubiquitination and degradation of substrate proteins [30],[31]. Similarly, a temperature-sensitive allele of E1 in yeast dramatically reduces ubiquitin conjugation and also leads to cell cycle arrest [32]. Conditional alleles have also been isolated in Drosophila in a screen for suppressors of hid-induced apoptosis during eye development [33]. Detailed characterization demonstrated the complexity of ubiquitin regulation in this system. Whereas weak alleles of the E1-encoding Uba1 gene block apoptosis, strong alleles promote cell cycle arrest and death. Furthermore, these pro-apototic alleles promote non-autonomous proliferation in adjacent cells via elevated levels of Notch signaling. We report here the isolation of a temperature-sensitive mutation in the C. elegans uba-1 gene, which encodes the sole E1 enzyme in this organism. Prior results for RNAi of uba-1 reported maternal sterility and embryonic lethality, with defects in meiotic progression [34]–[36]. The uba-1(it129) mutation recapitulates these phenotypes and also reveals several novel functions, including roles in sperm fertility, body size, and sex-specific development. The uba-1(it129) mutation reduces in vivo levels of ubiquitin conjugates and causes a delay in meiotic progression in the early embryo, consistent with a reduction in E1 activity. The uba-1(it129) mutation also demonstrates synthetic lethal interactions with known components of the anaphase-promoting complex and, as such, provides a sensitized genetic background for identifying new in vivo functions for other components of the ubiquitin cascade. Results Phenotypic Characterization The temperature-sensitive it129 allele was isolated by Diane Shakes and, on the basis of sperm sterility and larval lethality, was provisionally designated as spe-32 (S. Ward, pers. comm.). We have determined that spe-32 is allelic to uba-1 (see below), the sole E1 ubiquitin-activating enzyme in C. elegans, and have adopted the latter gene name for the sake of clarity. Our detailed characterization of uba-1(it129) demonstrates a number of phenotypes, some of which are sex-specific, in addition to those mentioned above. Different phenotypes are manifested at different developmental stages (summarized in Table 1). To facilitate characterization, temperature-shift experiments were performed with age-synchronized populations of uba-1(it129) hermaphrodites. Adults shifted to the restrictive temperature produce dead embryos, and the number is equal to the number of progeny produced by wild-type animals at this temperature (Figure 1A
Larvae that are shifted to the restrictive temperature at the L3 stage exhibit normal somatic development. However, reproduction is adversely affected in the adult hermaphrodite. These sterile animals lay only unfertilized oocytes instead of embryos, but produce viable progeny when mated to wild type males, indicating that the sterility is sperm-specific (Figure 1C All of the above phenotypes are fully recessive, as heterozygous hermaphrodites are indistinguishable from wild type. These phenotypes are largely though not completely rescued in uba-1(it129) homozygous animals at the permissive temperature. There is an increase in embryonic lethality as well as a decrease in the number of embryos produced (Figure 1A In the course of generating heterozygous strains for phenotypic characterization, we observed strong maternal effect rescue of the early developmental defects. Homozygous uba-1(it129) progeny derived from +/uba-1(it129) hermaphrodites reared at the restrictive temperature exhibited little embryonic or larval lethality (Table 2). Maternal rescue was not complete for all phenotypes; although the homozygous hermaphrodites developed normally into adulthood, sperm-specific sterility was still observed in these animals. We also tested for paternal rescue by mating uba-1(it129)/+ heterozygous males to uba-1(it129) homozygous hermaphrodites. Again, embryonic and larval lethality (though not sperm sterility) were largely rescued (Table 2). Because the presence of a single wild-type copy of uba-1 in either the hermaphrodite or male parent effectively suppresses embryonic and larval lethality in homozygous mutant progeny, it suggests that the maternal or paternal contribution of UBA-1 protein is sufficient to allow somatic development to proceed normally until adulthood.
Male-Specific Phenotypes To facilitate the phenotypic characterization of males, we constructed a uba-1(it129) him-5(e1490) strain [the him-5(e1490) mutation produces males via nondisjunction of the X chromosome] [37]. Temperature-shift experiments were performed with age-synchronized populations, and the same phenotypes were observed in males as above: embryonic and larval lethality and a reduction in body size (data not shown). Sperm-specific sterility of mutant males was assessed by crossing to fem-1(hc17) hermaphrodites, which lack sperm but produce oocytes that can be fertilized by mating. Experiments described below indicate that mating was successful but no cross-progeny were produced, demonstrating that male sperm are incapable of fertilization. Thus, the same array of defects are produced by the uba-1(it129) mutation in males and hermaphrodites. We also observed additional phenotypes in uba-1(it129) males. The most conspicuous phenotype in the adult was constitutive protraction of the spicules (Figure 2A
Additional abnormalities in the male copulatory apparatus were observed in animals reared at the restrictive temperature. The tail of the wild-type male possesses a cuticular fan containing nine pairs of sensory rays (Figure 2A The male tail structures are critical for mating behavior and sperm transfer, so aberrations in the fan or in spicule function might adversely affect male reproductive success. Sperm from wild-type males take precedence over hermaphrodite sperm such that only outcross progeny are produced until the male sperm are depleted, at which time the production of self progeny continues [38]. Male sperm produce male and hermaphrodite progeny in equal numbers, while hermaphrodite sperm produce exclusively hermaphrodite progeny. Therefore, the number of outcross progeny, an indicator of male reproductive success, can be readily calculated by determining the number of males produced. Reproductive success was ascertained for homozygous uba-1(it129) males grown at the permissive temperature. Some of these animals have protruding spicules, which might be predicted to impair sperm transfer. The fertility of uba-1(it129) hermaphrodites at 15°C demonstrates that sperm function is normal at this temperature, so the production of outcross progeny was used as an indicator of successful mating. Mating to wild-type males produced males and hermaphrodites in the expected 1 1 ratio, indicating that all of the offspring in the measured time interval resulted from fertilization by male sperm (Figure 2B 1 (data not shown). Therefore, the protruding spicule phenotype observed in uba-1(it129) males at the permissive temperature decreases the successful transfer of sperm for fertilization.Reproductive success was also characterized in the same manner for uba-1(it129) males shifted to the restrictive temperature at L3. No outcross progeny were observed from matings to either wild-type or fem-1(hc17) hermaphrodites. This failure might arise from the inability of sperm to fertilize the oocytes (as is true for hermaphrodite sperm at 25°C), or might be a consequence of the severe morphological defects in the male copulatory apparatus that occur at the restrictive temperature. A direct assessment of sperm transfer was performed to discriminate between the two possibilities. Males from him-5(e1490) strains that are wild-type or mutant for uba-1(it129) were raised at both 15°C and 25°C, stained with a fluorescent dye, then mated to fem-1(hc17) hermaphrodites that lacked sperm. Wild-type males reared at either temperature and mutant males reared at 15°C were successful in mating 50–70% of the time, as revealed by the presence of labeled sperm in the fem-1(hc17) hermaphrodites (Figure 2C An additional, sex-specific phenotype was observed in uba-1(it129) males: a late onset, progressive paralysis in two-thirds of the animals (Figure 2, D–F Sperm-Specific Defect of uba-1 Mutation Sperm development in C. elegans has been described in detail [39],[40], which allows the identification of specific cytological and functional defects in the developmental program that occur as a consequence of mutation. Normal spermatogenesis initiates from a mitotically dividing population of germ line stem cells. Primary spermatocytes separate from a syncytial cytoplasmic core and undergo a coordinated program of meiosis and differentiation. The two meiotic divisions give rise to four haploid spermatids with highly condensed nuclei. These small round cells separate from a larger residual body, which contains components not needed for subsequent steps in development. Activation by an extracellular signal converts the immotile spermatids into mature crawling spermatozoa capable of fertilization, and several compounds that promote activation in vitro have been identified [41]–[43]. Activation in hermaphrodites occurs in the spermatheca, where the mature spermatozoa are stored. Activation of male spermatids occurs at the time of insemination, and the male spermatozoa crawl from the uterus into the spermatheca. Fertilization takes place within the spermatheca as the oocyte squeezes into this chamber of hermaphrodite reproductive tract, and the newly formed zygote then passes into the uterus. Most of the spermatozoa are dislodged and must crawl back into the spermatheca to await the next oocyte. Sperm-specific sterility caused by the uba-1(it129) mutation was characterized in greater detail, beginning with the early events leading to spermatid formation. DAPI staining of L4 and young adult hermaphrodites and males revealed no differences in meiotic progression, the number of sperm produced, or (for hermaphrodites) their initial localization to the spermathecae (Figure 3
A secondary defect in sperm function was detected later in adult hermaphrodites. Spermatozoa are displaced from the spermatheca into the uterus by each passing oocyte, and must return to the spermatheca and await the next egg. Fertilization efficiency is essentially 100% in wild type animals, with nearly every sperm being utilized for reproduction [38]. Thus, the number of sperm in the spermatheca decreases in concordance with an increase in the number of progeny produced. Because uba-1(it129) spermatozoa are motile but incapable of fertilization, one might predict that numbers within the spermatheca would remain high throughout oocyte production. Instead, the opposite phenomenon was observed, as sperm counts declined more rapidly in uba-1(it129) hermaphrodites than in wild type (Figure 3B Identification of it129 as uba-1 The identity of the it129 allele was determined through a combination of genetic and physical mapping strategies (Figure 4A
Complementation tests confirmed that it129 is an allele of uba-1. The Gene Knockout Consortium (http://celeganskoconsortium.omrf.org) has generated a deletion allele, uba-1(ok1374), that removes much of the third and fourth exons and is predicted to be a null mutation (Figure 4B The ok1374 deletion is a putative null allele, while the it129 mutation is probably hypomorphic (i.e., reduction of function; see Discussion). Therefore, we sought to ascertain whether it129/ok1374 heterozygotes were more adversely affected than it129 homozygotes. Most of the phenotypes observed in the it129 homozygous animals are highly penetrant, making enhancement difficult to detect. However, data from the complementation assay for sperm-specific sterility strongly suggest a more severe defect in it129/ok1374 animals. Cross-fertilization of sterile it129 homozygous hermaphrodites by wild type males yields progeny with high viability (96%; see Figure 1C Germ cell development in C. elegans proceeds distally to proximally within the gonad, and is most readily distinguishable by changes in nuclear morphology [45]. In hermaphrodites, the proximal arm of the wild-type adult gonad contains a row of individual oocytes whose nuclei are arrested at diakinesis of meiosis I. Our analysis indicates that the germ lines of it129 homozygotes are similar to wild type hermaphrodites, and the proximal gonad contains morphologically normal oocytes whose six diakinetic bivalents are easily seen (Figure 4D In addition, we also observed a spermatogenesis defect in the germ line of males. Wild-type adult males accumulate large numbers of highly condensed spermatid nuclei within the seminal vesicle. The it129 homozygous males likewise contain an abundance of compact spermatid nuclei (Figure 4D Transgene rescue of it129 with the wild type uba-1 gene further confirmed its identification. Initial attempts at rescue by germ line microinjection indicated that worms might be exquisitely sensitive to the dosage of this gene. Control injections with the rol-6 marker [49] produced numerous F1 rolling progeny with stable transmission in subsequent generations. In contrast, coinjection of uba-1 with rol-6 at typical concentrations resulted in low brood sizes with very few F1 rollers and no stably transmitting lines, suggestive of transgene toxicity. To reduce the gene dosage, the concentration of uba-1 DNA was decreased relative to rol-6 and genomic N2 DNA was also included in the injections. At the lowest concentration tested, four of sixteen stably transmitting lines exhibited partial rescue of both sperm-specific sterility and embryonic lethality at the restrictive temperature. Therefore, the wild type uba-1 transgene is able to complement the it129 mutation. Expression of a uba-1::GFP reporter transgene has been reported in a variety of somatic tissues but not the germ line [50], although a functional role for UBA-1 in this tissue is indicated by the mutant phenotype. Transgenes are often silenced within the germ line, so in situ hybridization was employed to detect transcription of the endogenous uba-1 gene within the gonad. Abundant expression was detected in germ cells that had initiated meiosis in wild type hermaphrodites (during sperm and oocyte production) and males (Figure 5
Sequence determination of the uba-1 coding region from the it129-bearing strain revealed the molecular lesion. A single nucleotide substitution was detected that converts the proline at position 1024 to serine (Pro1024Ser, Figure 4B In vivo Defects in Ubiquitination and Embryogenesis The uba-1 gene encodes the only known E1 ubiquitin-activating enzyme in C. elegans, so a defect in its activity is predicted to impair subsequent steps in the enzymatic cascade and cause an overall decrease in the level of ubiquitination on substrate proteins. We tested this hypothesis directly by using ubiquitin-specific antibodies to assess the amount of ubiquitination in worm protein lysates. To control for variations in ubiquitination activity at different stages of development, we extracted protein from age-synchronized young adult hermaphrodites shifted as L3 larvae. Since these uba-1(it129) animals are infertile due to sperm-specific sterility, we included as an additional control a strain containing spe-26(it112) (a temperature-sensitive, sperm-specific sterile mutation). Western blots show a significant reduction in the amount of ubiquitin signal in uba-1(it129) protein extracts compared to wild-type and spe-26(it112) controls (Figure 6
Reduced ubiquitination is predicted to adversely impact proteasomal degradation of target proteins. Well-characterized roles for ubiquitin-mediated proteolysis in C. elegans occur during the early events of embryogenesis. The anaphase-promoting complex (APC) is an E3 ligase that is required for degradation of the meiotic inhibitor securin [53]. Complete loss of APC activity results in metaphase arrest of the one-celled embryo [19]. The uba-1(it129) mutation does not produce the one-celled arrest caused by loss of APC activity, but instead mimics the multicellular embryonic lethality resulting from reduced APC function. This phenotype is produced by hypomorphic mutations in APC components or by synthetic interactions between some pairs of temperature-sensitive alleles (i.e., each single mutation has no effect at the permissive temperature, whereas the combination of both mutations causes maternal embryonic lethality) [29]. Since UBA-1 and APC function in the same enzymatic cascade, mutations in both might likewise exhibit a synthetic interaction. Therefore, we tested the uba-1(it129) allele in combination with APC components. Double mutants of uba-1(it129) with either the APC subunit mat-3(or180) [19] or the APC activator fzy-1(h1983) [53] resulted in maternal embryonic lethality at the permissive temperature (Table 3).
Early embryogenesis was examined in uba-1(it129) adult hermaphrodites shifted to 25° for defects in meiotic progression or A-P polarity in the first cell division. An oma-1::GFP transgene was used to allow visualization of embryonic polarity [54]. In wild-type hermaphrodites, OMA-1::GFP protein is evenly distributed throughout the cytosol and excluded from the intact pronuclei of the one-celled embryo. Our observations at 25°C indicate that the protein is also concentrated on the sperm centrioles and mitotic spindle. Ubiquitin-mediated proteolysis at the first cell division degrades the bulk of OMA-1::GFP. The protein is absent in the anterior (A) cell of the two-celled embryo, and the remaining OMA-1::GFP becomes associated with P granules in the posterior (P) cell. In uba-1(it129) animals, the pattern of OMA-1::GFP in one-celled embryos is indistinguishable from wild-type. OMA-1::GFP degradation during the first cell division is likewise identical, and the protein persists only in the P cell. However, progression of the zygote through the first division is slower than normal for uba-1(it129) embryos. The delayed progression leads to an increase in the number of one-celled embryos within the uterus, which is easily visualized by the presence of OMA-1::GFP (Figure 7A
The delay in progression through the first embryonic division was examined in greater detail. Upon fertilization, the oocyte nucleus completes the first and second meiotic divisions. The oocyte and sperm pronuclei meet and fuse, then undergo the first mitotic division. The percentage of embryos observed at each of these stages (meiosis, pronuclear migration and fusion, and mitosis) was determined for wild-type and uba-1(it129) animals. The fraction of one-celled embryos in the meiotic and pronuclear stages was equivalent in wild type, but approximately two-fold higher in the meiotic stage for uba-1(it129) embryos (Figure 7C Discussion We report here the isolation and characterization of a temperature-sensitive mutation of the uba-1 gene, which encodes the E1 ubiquitin-activating enzyme of C. elegans. Activation by E1 is the first step in the enzymatic pathway that leads to the conjugation of ubiquitin to target proteins. Manipulation of E1 activity by temperature shift provides a mechanism for identifying the many roles for ubiquitination throughout development. Effects of the uba-1(it129) mutation are manifested at both the organismal (i.e., embryonic and larval lethality, reduction in body size) and cellular (sperm-specific sterility) levels, and also result in sex-specific differences of developmental (formation of the male copulatory apparatus) and post-developmental (late-onset male paralysis) processes. The uba-1(it129) mutation causes a substantial reduction of in vivo levels of ubiquitin-conjugated substrates, exhibits synthetic embryonic lethality with components of the anaphase promoting complex (an E3 ubiquitin ligase), and produces delays in early embryonic events known to be regulated by ubiquitin-mediated proteolysis. Taken together, the data indicate that the uba-1(it129) mutation results in a temperature-sensitive reduction in its ubiquitin-activating enzymatic activity. Since the uba-1 gene product is the only E1 enzyme in C. elegans, a reduction in its activity is predicted to negatively impact the function of E2 and E3 enzymes globally. This reduction would extend the half-life of proteins normally targeted for the proteasome, as well as altering the localization and/or activities of other ubiquitin-conjugated substrates. Some of these downstream pathways will be more or less sensitive to a reduction in E1 activity, but the result will be a decrease in the rate of ubiquitination for a wide variety of substrate proteins. In support of this model, Western blotting with anti-ubiquitin antibodies demonstrated an overall reduction in ubiquitin labeling of extracts from the uba-1(it129) mutant strain (Figure 6 An alternative hypothesis, that the uba-1(it129) mutation blocks only one or a few E2/E3 pathways, is less likely. The observed reduction of in vivo ubiquitination in the mutant would require that the bulk of ubiquitin conjugation be mediated by one or a few E3 ligases; however, the hundreds of E3s that are present in C. elegans argue against this model. Furthermore, the range of phenotypes produced by the uba-1 mutation is much broader than those reported for inactivation of any single E2 or E3 enzyme [55], consistent with its participation in multiple E2/E3 pathways. We clearly demonstrate genetic interactions between uba-1(it129) and one E3 pathway, the APC, via synthetic embryonic lethality with mat-3 or fzy-1 alleles. However, the sperm-specific fertilization defect appears to involve a different E3 pathway. This phenotype is not observed in APC mutants but has been reported for mutations in spe-16, which has recently been determined to encode an E3 ubiquitin ligase homolog (Steve L'Hernault, personal communication). Some effects of the uba-1 mutation can be interpreted in light of the variety of phenotypes that arise from the loss of individual E2 or E3 activities. For example, embryonic and larval lethality have been reported for a number of E2 and E3 homologs in large-scale RNAi screens [34]–[36]. However, the majority of these genes have not been further characterized and, absent additional knowledge of which proteins are substrates for particular E2 and E3 enzymes, it's difficult to speculate on the molecular mechanisms responsible for the observed lethality. In other instances, the uba-1 mutant phenotype suggests a previously unidentified role for ubiquitination. Body size in C. elegans is governed by a canonical TGF-ß signal transduction pathway that initiates with the DBL-1 ligand [56],[57]. Components of the TGF-ß pathway in other organisms are known to be regulated by ubiquitin conjugation [58]. Different ubiquitin modifications produce antagonistic effects on signal transduction: mono-ubiquitination of Co-Smad stabilizes the protein and promotes signaling, while poly-ubiquitination of R-Smad leads to its proteasomal degradation and down-regulation of signaling. Given the effects of the uba-1 mutation on C. elegans body size, it seems likely that components of the DBL-1/TFG-ß pathway are similarly regulated by ubiquitin. The sperm-specific sterility of uba-1(it129), coupled with the recent identification of spe-16 as an E3 ubiquitin ligase homolog (Steve L'Hernault, personal communication), indicate a previously uncharacterized role for ubiquitin in C. elegans spermatogenesis. Ubiquitination is known to be essential for sperm function in a wide variety of organisms, and roles in mammalian spermatogenesis include regulation of the meiotic cell cycle, histone modification and chromatin remodeling, protein sorting during sperm differentiation, and quality control for defective sperm [59]–[62]. In C. elegans, early events like meiosis appear unaffected by the uba-1(it129) mutation, suggesting that the infertility of these morphologically normal spermatozoa is due to a later defect in sperm development. In a manner analogous to mammalian sperm, ubiquitination in C. elegans might function in protein sorting as the spermatids divide from the residual body. Errors in this process are known to adversely affect sperm function: mutation of spe-15, which encodes a myosin homolog, impairs the asymmetric segregation of proteins during spermatid budding and causes sperm-specific sterility [63]. Alternatively, ubiquitination might promote proteasomal degradation of a protein that inhibits fertilization, and decreased activity of UBA-1 would lead to inappropriate persistence of the proposed inhibitor. Spermatid activation and downstream events occur in the absence of new protein synthesis, so degradation of pre-existing component(s) is a plausible mechanism of regulation. Another possibility is that uba-1(it129) infertility might reflect a role for ubiquitin-mediated proteolysis in the sperm-oocyte interaction. Fertilization in ascidians is mediated by an extracellular enzyme from sperm that conjugates ubiquitin to a sperm receptor on the egg surface, leading to its degradation via the proteasome [64]. Ongoing analysis is designed to determine if one (or more) of these hypotheses is correct. Multiple E3 ligases are involved in formation of the reproductive structures of the male tail, so the defects observed in uba-1 mutant males might arise from impairment of one or more known ubiquitination pathways. Mutation of mat-1, which encodes the CDC27 subunit of the APC, causes a diminution in the size of the fan and sensory rays similar to the defect produced by uba-1(it129) [29]. The heterochronic gene lin-41, which encodes a homolog of the RING finger subclass of E3 ligases, is also required for proper formation of the male tail. A decrease in LIN-41 function causes precocious retraction of the male tail so that the fan and rays are reduced or absent [65],[66]. The DBL-1/TGF-ß pathway (mentioned above) that determines body size also plays a role in formation of the spicules [67], and might be implicated in the protruding spicule phenotype of uba-1(it129) males. The late-onset paralysis and associated lethality produced by the uba-1(it129) mutation is unusual in two regards: it is sex-specific, affecting only males, and can be induced after all somatic development is complete. There are few reports of such post-developmental phenotypes for C. elegans, and this property suggests a defect in the maintenance of neuronal and/or muscle function rather than its establishment. Roles for ubiquitination in C. elegans neuromuscular activity have been reported previously. Multiple E2 conjugating enzymes have been implicated in polyglutamine protein aggregation in muscle [68]. E3 ligase complexes that have been demonstrated to affect either muscle or neuronal function include CHN-1/UDF-2, APC, KEL-8/CUL-3, SCF/FSN-1/RPM-1, SCF/LIN-23, and SCF/SEL-10 [15], [16], [69]–[72]. However, the paralysis of uba-1(it129) males is distinct from the more subtle neuromuscular defects reported for other ubiquitin pathway components such as APC (decreased duration of forward movement) or KEL-8/CUL-3 (changes in nose touch response and spontaneous reversal frequency) [15],[16]. Furthermore, functional roles for all of these enzymes have been demonstrated in hermaphrodites, so the sex-specific ubiquitination that is responsible for male paralysis remains to be elucidated. Why are male-specific processes, including the fertility defect of the male gamete (i.e., sperm), so acutely sensitive to the level of UBA-1 activity? One intriguing possibility involves the recently discovered role for ubiquitin-mediated proteolysis in the sex determination pathway. The TRA-1 transcription factor is the critical regulator of somatic and germ line sex determination and acts primarily as an inhibitor of male sexual fate [73]. Three FEM proteins negatively regulate TRA-1 activity and thereby promote male cell fates, including sperm development in hermaphrodites [74]. Starostina et al. [12] demonstrate that the FEM proteins form an E3 ubiquitin ligase complex with CUL-2 that binds to and promotes proteasome-dependent degradation of TRA-1. Impairment of UBA-1 function by mutation would be predicted to decrease activity of the FEM/CUL-2 E3 complex, leading to an increase in TRA-1 levels that would inhibit male developmental processes. This weakly feminizing effect might act synergistically with one or more of the E3 pathways described above. If this hypothesis is correct, then some of the sex-specific defects of the uba-1 mutation might be suppressed by a decrease in TRA-1 activity. The observation of synthetic embryonic lethality between uba-1(it129) and mutations in components of the APC suggests a powerful approach for identifying new functions for downstream components of the ubiquitin pathway. A number of E2 and E3 homologs exhibit detectable phenotypes in genome-scale RNAi screens, but the majority are indistinguishable from wild type [34],[35]. One possible explanation is that many of these enzymes are functionally redundant, and that the determination of their roles will require inactivation of multiple E2s or E3s. Alternatively, in some instances the reduction of E2 or E3 levels by RNAi might be insufficient to disrupt function. However, the uba-1 mutation provides a sensitized genetic background for detecting decreased activity of downstream enzymes. Reanalysis by RNAi screening of the E2 and E3 homologs in the uba-1 mutant strain is likely to reveal novel functions for a number of those genes whose roles are currently unknown. Materials and Methods Genetics C. elegans strains were derived from the wild-type isolate N2 (Bristol) and contained one or more of the following mutations: uba-1(it129)IV, uba-1(ok1374)IV, dpy-20(e1282)IV, fem-1(hc17)IV, fem-3(q20)IV, him-5(e1490)V, mat-3(or180)III, fzy-1(h1983)II, spe-26(it112), or chromosome IV deficiencies eDf19 or mDf7. A linked uba-1(it129) dpy-20(e1282) double mutant strain was generated to facilitate discrimination of homozygous and heterozygous lines in some experiments. The integrated oma-1::GFP transgenic line was constructed by Reuyling Lin [54]. Strains were maintained on NGM plates seeded with E. coli strain OP50. Age-synchronized populations of embryos were obtained by sodium hypochlorite treatment of gravid hermaphrodites. Strains were maintained at 15°C and shifted to 25°C as indicated for phenotypic analysis. Genetic manipulations were carried out according to Brenner [75]. Microscopy Microscopy was performed with an Olympus BX51TF or Zeiss Axio Imager equipped with Nomarski DIC objectives and appropriate filter sets for fluorescent imaging and cooled CCD camera for image capture. Images were processed using the AxioVision (release 4.6) package and prepared for publication using Adobe Photoshop CS v. 9.0.2. Intact animals were typically mounted on 2% agarose pads for imaging. Body length was measured from captured images using ImageJ software v. 1.38. Sperm Assays Sperm morphology was assessed by dissection of gonads from adult hermaphrodites or males in SM medium [43]. Nuclear DNA morphology was visualized by DAPI staining of sperm from dissected gonads. In vitro activation of male spermatids was by treatment with monensin on poly-lysine-coated slides [43]. Motility and localization of hermaphrodite sperm were determined in intact animals by fixation and staining with DAPI, then counting the number of sperm nuclei in the spermathecae and uterus. Sperm transfer was ascertained by vital staining of males [76] with the mitochondrial dye MitoTracker Red CMXRos (Molecular Probes), then mating to unstained hermaphrodites anesthetized with tricaine and tetramisole. After 12 or 24 h, fluorescently-labeled male sperm within the hermaphrodite reproductive tract were visualized by microscopy using rhodamine filters. Self-fertility of hermaphrodites was assessed by shifting individual L3 animals to 25°C and counting the entire brood size. Cross-fertility of males was determined by mating with individual wild-type hermaphrodites or fem-1(hc17) females, then counting the number of male and hermaphrodite progeny produced by each animal after mating. Cloning and Molecular Analysis The uba-1(it129) mutation was localized to chromosome IV between elt-1 and dpy-20 by three-factor crosses. Single nucleotide polymorphisms that affect restriction sites (snip-SNPs) were employed as physical mapping markers of individual uba-1(it129) dpy-20(e1282) recombinants with Hawaiian strain CB4856 [44]. Deficiency mapping was performed by complementation testing in uba-1(it129)/Df heterozygous strains. RNAi of candidate genes was performed by feeding [77] and assessed by phenocopy of F1 embryonic lethality for treated adult hermaphrodites and by defects in adult tail morphology for treated L3 males. Complementation of the uba-1(ok1374) deletion allele was determined by generating it129/ok1374 heterozygous animals and performing temperature-shift assays as described for phenotypic characterization. Transformation rescue [49] was obtained by germ line microinjection of a 6.0 kb genomic fragment of the wild-type uba-1 gene mixed with plasmid pRF4, which contains the dominant roller marker rol-6(su1006), and linearized N2 genomic DNA at concentrations of 1, 50, and 100 µg/ml, respectively. Stable roller transgenic lines were generated from uba-1(it129) hermaphrodites maintained at 15°C, then rescue of sperm-specific sterility and embryonic lethality was scored after shifting to 25°C. The molecular lesion of the uba-1(it129) allele was identified by PCR amplification of the 6.0 Kb uba-1 genomic interval from mutant worms followed by sequence determination. In situ hybridization for uba-1 germ line expression was performed on dissected gonads following fixation [78]. Digoxigenin-labeled, single-stranded sense and antisense probes were generated from a 1 kb cDNA fragment by linear amplification according to the manufacturer's protocol (Roche, Indianapolis, IN). Following hybridization, probe detection was by colorimetric assay with alkaline phosphatase-conjugated anti-digoxigenin antibodies and NBT/BCIP substrate. Western blot analysis was performed on soluble worm lysates from age-synchronized young adult hermaphrodites shifted to 25° as L2 larvae. Lysates were obtained by one freeze-thaw cycle, homogenization, and centrifugation for 10 minutes at 10,000 RCF. Protein concentration of the soluble fraction was quantified by Bradford assay. 10 µg samples were fractionated by SDS-PAGE and transferred to PVDF membranes. Ubiquitin-conjugated proteins were detected by mouse anti-ubiquitin monoclonal antibody (1°) followed by HRP-conjugated goat anti-mouse IgG polyclonal antibody (2°; both Stressgen, Ann Arbor, MI). Duplicate gels were stained with Gelcode Blue (Pierce, Rockford, IL) to visualize total protein. Acknowledgments We wish to thank Diane Shakes for isolating and Sam Ward for providing the uba-1(it129) allele, Michael Stitzel of Geraldine Seydoux's lab for providing the oma-1::GFP strain, the Caenorhabditis Genetics Center and C.elegans Gene Knockout Consortium for providing strains, Andy Golden for providing strains and suggesting the synthetic lethal experiment, Eugene Melamud for assistance with the structural prediction, Sara Hapip for assistance with the RNAi candidate screen, and members of the lab and the Baltimore/Washington worm community for fruitful discussions. Footnotes The authors have declared that no competing interests exist. This work was supported in part by National Science Foundation grant number 0445684 to HES. References 1. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425–479. [PubMed] 2. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer. 2006;6:369–381. [PubMed] 3. Ardley HC, Robinson PA. The role of ubiquitin-protein ligases in neurodegenerative disease. Neurodegener Dis. 2004;1:71–87. [PubMed] 4. Schnell JD, Hicke L. Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J Biol Chem. 2003;278:35857–35860. [PubMed] 5. Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J. 2005;24:3353–3359. [PubMed] 6. Mukhopadhyay D, Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science. 2007;315:201–205. [PubMed] 7. Geetha T, Kenchappa RS, Wooten MW, Carter BD. TRAF6-mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor. EMBO J. 2005;24:3859–68. [PubMed] 8. Chiu RK, Brun J, Ramaekers C, Theys J, Weng L, et al. Lysine 63-polyubiquitination gurads against translesion synthesis-induced mutations. PLoS Genet. 2006;2:e116. [PubMed] 9. Lim KL, Chew KC, Tan JM, Wang C, Chung KK, et al. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci. 2005;25:2002–2009. [PubMed] 10. Hershko A, Heller H, Elias S, Ciechanover A. Components of ubiquitin-protein ligase system Resolution, affinity purification, and role in protein breakdown. J Biol Chem. 1983;258:8206–8214. [PubMed] 11. Jackson PK, Eldridge AG, Freed E, Furstenthal L, Hsu JY, et al. The lore of the RINGS: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. 2000;10:429–439. [PubMed] 12. Starostina NG, Lim JM, Schvarzstein M, Wells L, Spence AM, et al. A CUL-2 ubiquitin ligase containing three FEM proteins degrades TRA-1 to regulate C. elegans sex determination. Dev Cell. 2007;13:127–129. [PubMed] 13. Feng H, Zhong W, Punkosdy G, Gu S, Zhou L, et al. CUL-2 is required for the G1-to-S phase transition and mitotic chromosome condensation in Caenorhabditis elegans. Nat Cell Biol. 1999;1:486–492. [PubMed] 14. Burbea M, Dreier L, Dittman JS, Grunwald ME, Kaplan JM. Ubiquitin and AP180 regulate the abundance of GLR-1 glutamate receptors at postsynaptic elements in C. elegans. Neuron. 2002;35:107–120. [PubMed] 15. Juo P, Kaplan JM. The anaphase-promoting complex regulates the abundance of GLR-1 glutamate receptors in the ventral nerve cord of C. elegans. Curr Biol. 2004;14:2057–2062. [PubMed] 16. Schaefer H, Rongo C. KEL-8 is a substrate receptor for CUL-3-dependent ubiquitin ligase that regulates synaptic glutamate receptor turnover. Mol Cell Biol. 2006;17:1250–1260. 17. Frazier T, Shakes D, Hota U, Boyd L. Caenorhabditis elegans UBC-2 functions with the anaphase-promoting complex but also has other activities. J Cell Sci. 2004;117:5427–5435. [PubMed] 18. Bowerman B, Kurz T. Degrade to create: developmental requirements for ubiquitin-mediated proteolysis during early C. elegans embryogenesis. Development. 2006;133:773–784. [PubMed] 19. Golden A, Sadler PL, Wallenfang MR, Schumacher JM, Hamill DR, et al. Metaphase to anaphase (mat) transition-defective mutants in Caenorhabditis elegans. J Cell Biol. 2000;151:1469–1482. [PubMed] 20. Davis ES, Wille L, Chestnut BA, Sadler PL, Shakes DC, et al. Multiple subunits of the Caenorhabditis elegans anaphase-promoting complex are required for chromosome segregation during meiosis I. Genetics. 2002;160:805–813. [PubMed] 21. Bosu DR, Kipreos ET. Cullin-RING ubiquitin ligases: global regulation and activation cycles. Cell Div. 2008;3:7. [PubMed] 22. Pintard L, Willis JH, Willems A, Johnson JL, Srayko M, et al. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. Nature. 2003;425:311–316. [PubMed] 23. Xu L, Wei Y, Reboul J, Vaglio P, Shin TH, et al. BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature. 2003;425:316–321. [PubMed] 24. Kemphues KJ, Wolf N, Wood WB, Hirsh D. Two loci required for cytoplasmic organization in early embryos of Caenorhabditis elegans. Dev Biol. 1986;113:449–460. [PubMed] 25. Sonneville R, Gonczy P. Zyg-11 and cul-2 regulate progression through meiosis II and polarity establishment in C. elegans. Development. 2004;131:3527–3543. [PubMed] 26. Liu J, Vasudevan S, Kipreos ET. CUL-2 and ZYG-11 promote meiotic anaphase II and the proper placement of the anterior-posterior axis in C. elegans. Development. 2004;131:3513–3525. [PubMed] 27. DeRenzo C, Reese KJ, Seydoux Exclusion of germ plasm proteins from somatic lineages by cullin-dependent degradation. Nature. 2003;424:685–689. [PubMed] 28. Rappleye CA, Tagawa A, Lyczak R, Bowerman B, Aroian RV. The anaphase-promoting complex and separin are required for embryonic anterior-posterior axis formation. Dev Cell. 2002;2:195–206. [PubMed] 29. Shakes DC, Sadler PL, Schumacher JM, Abdolrasulnia M, Golden A. Developmental defects observed in hypomorphic anaphase-promoting complex mutants are linked to cell cycle abnormalities. Development. 2003;130:1605–1620. [PubMed] 30. Finley D, Ciechanover A, Varshavsky A. Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85. Cell. 1984;37:43–55. [PubMed] 31. Ciechanover A, Finley D, Varshavsky A. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell. 1984;37:57–66. [PubMed] 32. Ghaboosi N, Deshaies RJ. A conditional yeast E1 mutant blocks the ubiquitin-proteasome pathway and reveals a role for ubiquitin conjugates in targeting Rad23 to the proteasome. Mol Biol Cell. 2007;18:1953–1963. [PubMed] 33. Lee TV, Ding T, Chen Z, Rajendran V, Scherr H, et al. The E1 ubiquitin-activating enzyme Uba1 in Drosophila controls apoptosis autonomously and tissue growth non-autonomously. Development. 2008;135:43–52. [PubMed] 34. Jones D, Crowe E, Stevens TA, Candido EP. Functional and phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans: ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-like proteins. Genome Biol. 2002;3:RESEARCH00021-15. 35. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 2003;421:231–237. [PubMed] 36. Sonnichsen B, Koski LB, Walsh A, Marschall P, Neumann B, et al. Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature. 2005;434:462–469. [PubMed] 37. Hodgkin JA, Horvitz HR, Brenner S. Nondisjunction mutants of the nematode Caenorhabditis elegans. Genetics. 1979;91:67–94. [PubMed] 38. Ward S, Carrel JS. Fertilization and sperm competition in the nematode Caenorhabditis elegans. Dev Biol. 1979;73:304–321. [PubMed] 39. Wolf N, Hirsh D, McIntosh JR. Spermatogenesis in males of the free-living nematode, Caenorhabditis elegans. J Ultrastruct Res. 1978;63:155–169. [PubMed] 40. Ward S, Argon Y, Nelson GA. Sperm morphogenesis in wild-type and fertilization-defective mutants of Caenorhabditis elegans. J Cell Biol. 1981;91:26–44. [PubMed] 41. Nelson GA, Ward S. Vesicle fusion, pseudopod extension and amoeboid motility are induced in nematode spermatids by the ionophore monensin. Cell. 1980;19:457–464. [PubMed] 42. Ward S, Hogan E, Nelson GA. The initiation of spermiogenesis in the nematode Caenorhabditis elegans. Dev Biol. 1983;98:70–79. [PubMed] 43. Shakes DC, Ward S. Initiation of spermiogenesis in C. elegans: a pharmacological and genetic analysis. Dev Biol. 1989;134:189–200. [PubMed] 44. Wicks SR, Yeh RT, Gish WR, Waterston RH, Plasterk RH. Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat Genet. 2001;28:160–164. [PubMed] 45. Hirsh D, Oppenheim D, Klass M. Development of the reproductive system of Caenorhabditis elegans. Dev Biol. 1976;49:200–219. [PubMed] 46. Berry LW, Westlund B, Schedl T. Germ-line tumor formation caused by activation of glp-1, a Caenorhabditis elegans member of the Notch family of receptors. Development. 1997;124:925–936. [PubMed] 47. Francis R, Barton MK, Kimble J, Schedl T. gld-1, a tumor suppressor gene required for oocyte development in Caenorhabditis elegans. Genetics. 1995;139:579–606. [PubMed] 48. Subramanian K, Seydoux G. Dedifferentiation of primary spermatocytes into germ cell tumors in C. elegans lacking the pumilio-like protein PUF-8. Curr Biol. 2003;13:134–139. [PubMed] 49. Mello CC, Kramer JM, Stinchcomb D, Ambros V. Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 1991;10:3959–3970. [PubMed] 50. McKay SJ, Johnsen R, Khattra J, Asano J, Baillie DL, et al. Gene expression profiling of cells, tissues and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol. 2004;68:159–169. [PubMed] 51. Lois LM, Lima CD. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1. EMBO J. 2005;24:439–451. [PubMed] 52. Walden H, Podgorski MS, Schulman BA. Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8. Nature. 2003;422:330–334. [PubMed] 53. Kitagawa R, Law E, Tang L, Rose AM. The Cdc20 homolog, FZY-1, and its interacting protein, IFY-1, are required for proper chromosome segregation in Caenorhabditis elegans. Curr Biol. 2002;12:2118–2123. [PubMed] 54. Lin R. A gain-of-function mutation in oma-1, a C. elegans gene required for oocyte maturation, results in delayed degradation of maternal proteins and embryonic lethality. Dev Biol. 2003;258:226–239. [PubMed] 55. Kipreos ET. The C. elegans Research Community, editors. Ubiquitin-mediated pathways. WormBook. 2005. Available: http://www.wormbook.org. 56. Savage C, Das P, Finelli AL, Townsend SR, Sun CY, et al. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components. Proc Natl Acad Sci U S A. 1996;93:790–794. [PubMed] 57. Suzuki Y, Yandell MD, Roy PJ, Krishna S, Savage-Dunn C, et al. A BMP homolog acts as a dose-dependent regulator of body size and male tail patterning in Caenorhabditis elegans. Development. 1999;126:241–250. [PubMed] 58. Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol. 2007;19:176–184. [PubMed] 59. Baarends WM, Hoogerbrugge JW, Roest HP, Ooms M, Vreeburg J, et al. Histone ubiquitination and chromatin remodeling in mouse spermatogenesis. Dev Biol. 1999;207:322–333. [PubMed] 60. Sutovsky P, Moreno R, Ramalho-Santos J, Dominko T, Thompson WE, et al. A putative, ubiquitin-dependent mechanism for the recognition and elimination of defective spermatozoa in the mammalian epididymis. J Cell Sci. 2001;114:1665–1675. [PubMed] 61. Guardavaccaro D, Kudo Y, Boulaire J, Barchi M, Busino L, et al. Control of meiotic and mitotic progression by the F box protein beta-Trcp1 in vivo. Dev Cell. 2003;4:799–812. [PubMed] 62. Morokuma Y, Nakamura N, Kato A, Notoya M, Yamamoto Y, et al. MARCH-XI, a novel transmembrane ubiquitin ligase implicated in ubiquitin-dependent protein sorting in developing spermatids. J Biol Chem. 2007;282:24806–24815. [PubMed] 63. Kelleher JF, Mandell MA, Moulder G, Hill KL, L'Hernault SW, et al. Myosin VI is required for asymmetric segregation of cellular components during C. elegans spermatogenesis. Curr Biol. 2000;10:1489–1496. [PubMed] 64. Sawada H, Sakai N, Abe Y, Tanaka E, Takahashi Y, et al. Extracellular ubiquitination and proteasome-mediated degradation of the ascidian sperm receptor. Proc Natl Acad Sci U S A. 2002;99:1223–1228. [PubMed] 65. Slack FJ, Basson M, Liu Z, Ambros V, Horvitz HR, et al. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor. Mol Cell. 2000;5:659–669. [PubMed] 66. del Rio-Albrechtsen T, Kiontke K, Chiou SY, Fitch DH. Novel gain-of-function alleles demonstrate a role for the heterochronic gene lin-41 in C. elegans male tail tip morphogenesis. Dev Biol. 2006;297:74–86. [PubMed] 67. Baird SE, Ellazar SA. TGFbeta-like signaling and spicule development in Caenorhabditis elegans. Dev Biol. 1999;212:93–100. [PubMed] 68. Howard RA, Sharma P, Hajjar C, Caldwell KA, Caldwell GA, et al. Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation. BMC Cell Biol. 2007;8:32. [PubMed] 69. Hoppe T, Cassata G, Barral JM, Springer W, Hutagalung AH, et al. Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans. Cell. 2004;118:337–349. [PubMed] 70. Liao EH, Hung W, Abrams B, Zhen M. An SCF-like ubiquitin ligase complex that controls presynaptic differentiation. Nature. 2004;430:345–350. [PubMed] 71. Mehta N, Loria PM, Hobert O. A genetic screen for neurite outgrowth mutants in Caenorhabditis elegans reveals a new function for the F-box ubiquitin ligase component LIN-23. Genetics. 2004;166:1253–1267. [PubMed] 72. Ding M, Chao D, Wang G, Shen K. Spatial regulation of an E3 ubiquitin ligase directs selective synapse elimination. Science. 2007;317:947–951. [PubMed] 73. Hodgkin J. A genetic analysis of the sex-determining gene, tra-1, in the nematode Caenorhabditis elegans. Genes Dev. 1987;1:731–745. [PubMed] 74. Hansen D, Pilgrim D. Sex and the single worm: sex determination in the nematode C. elegans. Mech Dev. 1999;83:3–15. [PubMed] 75. Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77:71–94. [PubMed] 76. Hill KL, L'Hernault SW. Analyses of reproductive interactions that occur after heterospecific matings within the genus Caenorhabditis. Dev Biol. 2001;232:105–114. [PubMed] 77. Timmons L, Fire A. Specific interference by ingested dsRNA. Nature. 1998;395:854. [PubMed] 78. Lee MH, Schedl T. The C. elegans Research Community, editors. RNA in situ hybridization of dissected gonads. WormBook. 2006. Available: http://www.wormbook.org. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||
Annu Rev Biochem. 1998; 67():425-79.
[Annu Rev Biochem. 1998]Nat Rev Cancer. 2006 May; 6(5):369-81.
[Nat Rev Cancer. 2006]Neurodegener Dis. 2004; 1(2-3):71-87.
[Neurodegener Dis. 2004]J Biol Chem. 2003 Sep 19; 278(38):35857-60.
[J Biol Chem. 2003]Science. 2007 Jan 12; 315(5809):201-5.
[Science. 2007]EMBO J. 2005 Nov 16; 24(22):3859-68.
[EMBO J. 2005]J Neurosci. 2005 Feb 23; 25(8):2002-9.
[J Neurosci. 2005]J Biol Chem. 1983 Jul 10; 258(13):8206-14.
[J Biol Chem. 1983]Trends Cell Biol. 2000 Oct; 10(10):429-39.
[Trends Cell Biol. 2000]Dev Cell. 2007 Jul; 13(1):127-39.
[Dev Cell. 2007]J Cell Sci. 2004 Oct 15; 117(Pt 22):5427-35.
[J Cell Sci. 2004]Development. 2006 Mar; 133(5):773-84.
[Development. 2006]J Cell Biol. 2000 Dec 25; 151(7):1469-82.
[J Cell Biol. 2000]Genetics. 2002 Feb; 160(2):805-13.
[Genetics. 2002]Cell Div. 2008 Feb 18; 3():7.
[Cell Div. 2008]Nature. 2003 Aug 7; 424(6949):685-9.
[Nature. 2003]Cell. 1984 May; 37(1):43-55.
[Cell. 1984]Cell. 1984 May; 37(1):57-66.
[Cell. 1984]Mol Biol Cell. 2007 May; 18(5):1953-63.
[Mol Biol Cell. 2007]Development. 2008 Jan; 135(1):43-52.
[Development. 2008]Nature. 2005 Mar 24; 434(7032):462-9.
[Nature. 2005]Genetics. 1979 Jan; 91(1):67-94.
[Genetics. 1979]Dev Biol. 1979 Dec; 73(2):304-21.
[Dev Biol. 1979]J Ultrastruct Res. 1978 May; 63(2):155-69.
[J Ultrastruct Res. 1978]J Cell Biol. 1981 Oct; 91(1):26-44.
[J Cell Biol. 1981]Cell. 1980 Feb; 19(2):457-64.
[Cell. 1980]Dev Biol. 1989 Jul; 134(1):189-200.
[Dev Biol. 1989]Dev Biol. 1979 Dec; 73(2):304-21.
[Dev Biol. 1979]Nat Genet. 2001 Jun; 28(2):160-4.
[Nat Genet. 2001]Nature. 2003 Jan 16; 421(6920):231-7.
[Nature. 2003]Dev Biol. 1976 Mar; 49(1):200-19.
[Dev Biol. 1976]Development. 1997 Feb; 124(4):925-36.
[Development. 1997]Genetics. 1995 Feb; 139(2):579-606.
[Genetics. 1995]Curr Biol. 2003 Jan 21; 13(2):134-9.
[Curr Biol. 2003]EMBO J. 1991 Dec; 10(12):3959-70.
[EMBO J. 1991]Cold Spring Harb Symp Quant Biol. 2003; 68():159-69.
[Cold Spring Harb Symp Quant Biol. 2003]EMBO J. 2005 Feb 9; 24(3):439-51.
[EMBO J. 2005]Nature. 2003 Mar 20; 422(6929):330-4.
[Nature. 2003]Curr Biol. 2002 Dec 23; 12(24):2118-23.
[Curr Biol. 2002]J Cell Biol. 2000 Dec 25; 151(7):1469-82.
[J Cell Biol. 2000]Development. 2003 Apr; 130(8):1605-20.
[Development. 2003]J Cell Biol. 2000 Dec 25; 151(7):1469-82.
[J Cell Biol. 2000]Curr Biol. 2002 Dec 23; 12(24):2118-23.
[Curr Biol. 2002]Dev Biol. 2003 Jun 1; 258(1):226-39.
[Dev Biol. 2003]Nature. 2005 Mar 24; 434(7032):462-9.
[Nature. 2005]Proc Natl Acad Sci U S A. 1996 Jan 23; 93(2):790-4.
[Proc Natl Acad Sci U S A. 1996]Development. 1999 Jan; 126(2):241-50.
[Development. 1999]Curr Opin Cell Biol. 2007 Apr; 19(2):176-84.
[Curr Opin Cell Biol. 2007]Dev Biol. 1999 Mar 15; 207(2):322-33.
[Dev Biol. 1999]J Biol Chem. 2007 Aug 24; 282(34):24806-15.
[J Biol Chem. 2007]Curr Biol. 2000 Nov 30; 10(23):1489-96.
[Curr Biol. 2000]Proc Natl Acad Sci U S A. 2002 Feb 5; 99(3):1223-8.
[Proc Natl Acad Sci U S A. 2002]Development. 2003 Apr; 130(8):1605-20.
[Development. 2003]Mol Cell. 2000 Apr; 5(4):659-69.
[Mol Cell. 2000]Dev Biol. 2006 Sep 1; 297(1):74-86.
[Dev Biol. 2006]Dev Biol. 1999 Aug 1; 212(1):93-100.
[Dev Biol. 1999]BMC Cell Biol. 2007 Jul 30; 8():32.
[BMC Cell Biol. 2007]Curr Biol. 2004 Nov 23; 14(22):2057-62.
[Curr Biol. 2004]Cell. 2004 Aug 6; 118(3):337-49.
[Cell. 2004]Science. 2007 Aug 17; 317(5840):947-51.
[Science. 2007]Genes Dev. 1987 Sep; 1(7):731-45.
[Genes Dev. 1987]Mech Dev. 1999 May; 83(1-2):3-15.
[Mech Dev. 1999]Dev Cell. 2007 Jul; 13(1):127-39.
[Dev Cell. 2007]Nature. 2003 Jan 16; 421(6920):231-7.
[Nature. 2003]Dev Biol. 2003 Jun 1; 258(1):226-39.
[Dev Biol. 2003]Genetics. 1974 May; 77(1):71-94.
[Genetics. 1974]Dev Biol. 1989 Jul; 134(1):189-200.
[Dev Biol. 1989]Dev Biol. 2001 Apr 1; 232(1):105-14.
[Dev Biol. 2001]Nat Genet. 2001 Jun; 28(2):160-4.
[Nat Genet. 2001]Nature. 1998 Oct 29; 395(6705):854.
[Nature. 1998]EMBO J. 1991 Dec; 10(12):3959-70.
[EMBO J. 1991]